Syllabus

From FETAL PRECURSOR CELL TRANSPLANTATION (FPCT)
Jump to: navigation, search

The syllabus on the use of BCRO fetal cell transplantation (BCRO FCT) as a treatment of incurable/ untreatable diseases of all organ systems


1/ Genetic diseases

All of known ~4,500 genetic diseases – all incurable by current medicine controlled by the Big Pharma – can be successfully treated by BCRO FCT!

Such a huge statement can be made despite the fact that there is no sufficient evidence of such treatment results for many extremely/very rare, genetic diseases. In my experience, whenever I was asked to treat such patient, the result was a success (of various degree) in practically all of correctly(!) diagnosed cases.

However, it is mandatory that the BCRO FCT treatment is done as soon as the diagnosis was made, i.e. without any major delay. The later in life the patient gets the treatment, the lesser is the chance of success. This applies in particular to the diseases of central nervous system in children, where all BCRO FCT treatments must be completed before reaching the 4th year of life, with exception of classical autism (of Kanner).

Central nervous system is the sole system of the human body, the development of which is not completed until the end of 4th year of life, i.e. the diseases of central nervous system respond to the BCRO FCT very well until then, but the same cannot be expected later on. Human being is the sole member of animal kingdom completely unprepared to live independently up until one year of age, i.e. no Tarzan could survive alone in Nature during the first year of his life, without the nurturing of his gorilla ‘mother’.

Our International Institute of Biological Medicine in Moscow, in existence from 1990 till 1997, carried out a clinical research whereby all human newborns born with Apgar score 1 – 3 , i.e. with miniscule capacity to survive, and to develop as normal human beings, received CT scan of their brain at the age of 2 weeks (no MRI was available yet then) and if the classical radiological sign of ‘peri-ventricular malacia’ was found, then at 6 weeks of life the first fetal cell transplantation of periventricular medulla alba of brain was carried out, even though no official neurological diagnosis was obtained as yet. Same treatment was repeated in 4 months, and again in another 4 months, following which the clinical diagnosis was usually possible to obtain, that explained the reason(s) for low Apgar score. Later on, after the age of 1 year, fetal cell transplants of other parts of the brain and of other body organs were added, as needed.

Such very early BCRO FCT treatments were very promising in cases, where the newborn was extremely desired by the parents.


2/ Chromosomal diseases, such as Down syndrome, and their treatment by fetal cell transplantation, proved to the world that hopeless inborn childhood diseases can be helped by this treatment quite well. Major West German statistics of 1950 – 1990’s proved that fetal cell transplantation following the rules, described above under ‘genetic diseases’, did allow Down syndrome children to enter regular German public schools, which are more difficult, than the private ones, successfully finish 8 years’ course of studies, obtain vocational education, which allowed them to get regular jobs, in at least 50% of instances.

There has been also a success in treatment of Turner syndrome, Klinefelter syndrome, etc.


3/ Cerebral palsy

has been successfully treated by BCRO FCT for years as long as treatment began prior to the age of 4. With dyskinetic and ataxic forms there is frequently a therapeutic success even when BCRO FCT is begun even later, but not past the age of 10. In hypotonic forms BCRO FCT treatment should be tried once, even if the patient was past the age of 4, as there may be some therapeutic success, in which case additional treatment - every 4 months - should be done, as long there is appreciable positive result.


4/ Classical autism (Kanner autism), described in 1943) treatment by BCRO FCT was pioneered by E.M. Molnar, M.D., in 2007 in Hong Kong. The therapeutic success has been 100% in all of over 60 first patients, observad within 2 weeks. One BCRO FCT treatment was sufficient in all patients.

Up until 12 years of age subcutaneous implantation of BCRO FCT has been used. - Over the age of 12 intrathecal implantation of BCRO FCT (via lumbar puncture) must be carried out due to the closure of hemato-encephalic barrier, that becomes usually complete by the age of 12.

A few years ago an artificial (and illogical) classification of “autism spectrum disorders” was made, which bears no relationship to the reality. There are no ‘autism spectrum disorders’ known in Nature. BCRO FCT cannot be used to treat “autism spectrum disorders”, only for classical autism as defined by Dr. Kanner.


5/ Aging disease

has been at all times the most common reason for fetal cell transplantation therapy for 80 years. According to the West German statistics of 1950 – 1990’s 90% of 5 million patients, who received such therapy in that country, claimed that aging was the main reason for seeking such therapy, although naturally most of such patients suffered also from a variety of other medical conditions as well, typically at least of menopause or impotence.

According to the huge West German statistics German patients considered their ‘zellentherapie’ successful in 90% cases and seeked repetitive treatment at regular intervals.

With fast growing incidence of dementia, most commonly diagnosed as Alzheimer’s disease, the frequent component of handling aging disease is becoming the treatment of dementia by intrathecal BCRO FCT implantation via lumbar pu,ncture with exceptionally good results, even in the most advanced Alzheimer’s disease patients.

With BCRO FCT it is recommended that the treatment be repeated every 3 years, but in cases of dementia even more frequently, if necessary.


6/Diabetes mellitus type 1 with complications:

Every patient with diabetes mellitus type 1, or juvenile diabetes mellitus, will develop typical complications after 15 – 20 years, such as a diabetic retinopathy, the most common reason for blindness, diabetic nephropathy, leading cause of kidney failure, requiring hemodialysis and eventually kidney transplantation, diabetic polyneuropathy, causing intractable pain in lower extremities, diabetic lower extremity arterial disease, with gangrene of legs requiring amputation, brittle diabetes in children, complications of pregnancy, such as fetal death, female infertility. In all such patients BCRO FCT is the sole treatment for such complications, that works uniformly well every time.

USSR was the first country in the world that started a national project of treatment of complications of type 1 diabetes mellitus by human fetal transplantation in late 1970’s, by Prof.Dr. Shumakov and his team at Research Institute of Transplantology and Artificial Organs of USSR Ministry of Health in Moscow, which lead to the development of BCRO (rabbit) fetal cell transplantation in 1997.

Type 2 diabetes mellitus with diabetic complications(!) has been an indication for BCRO FCT, but limited only to cases of non-obese patients.

BCRO FCT has been mandatory(!) treatment for children with ‘brittle diabetes’ to prevent the fast development of the same diabetic complications. This applies also to the infertility, or fetal death in such diabetic patients.


7/ Other endocrine diseases:

Pituitary nanismus was the first disease in children successfully treated by animal fetal cell transplantation, already 100 years ago. Various forms of ‘hypothalamic syndromes’ have been treated successfully by fetal cell transplantation, such as: Sheehan syndrome, anorexia neurosa, bulimia, morbid obesity, intractable diabetes insipidus.

Diseases of adrenal cortex, such as adreno-cortical insufficiency, Addison’s disease, exhaustion of adrenal cortex by over-treatment of variety of diseases by cortisone, over-treatment by cortisone of various immunodefficiencies, all require timely BCRO FCT treatment.

Male infertility is the cause of infertility of a couple in 50% of instances. There is a successful treatment of this condition, the entire protocol is based on BCRO FCT, that could be carried out in many modern infertility clinic.

Premature menopause has reached epidemic proportions in the modern world, full of women that are overzealous in their competition with men. Hormonal therapy has been successful in one half of such patients only, while the second half of patients will have to rely on repeated BCRO FCT treatment. Such therapeutic protocol was developed by International Institute of Biological Medicine in Moscow in 1993/4.

Untreatable endometriosis, and uterine myomas, can be successfully handled, without hysterectomy or more aggressive surgical procedures, by BCRO FCT.

Untreatable chronic prostatitis with impotence have been successfully dealt with by fetal cell transplantation.

Untreatable hypothyroidism, congenital goiter or athyreosis, have been successfully treated by BCRO FCT. These treatment protocols were devised by IIBM in Moscow.


8/ Immune system deficiencies

are all incurable.

BCRO fetal cell transplantation is the sole immuno-stimulant known to the modern medicine that really works in every such instance.

The best proof is the treatment of a pre-terminal or terminal AIDS patients, 6 – 8 weeks before death: it is their last chance to stay alive by getting the BCRO FCT treatment. Such patients that look like a cadaver, and act like one, will (within 4 weeks after BCRO FCT) become a live human beings, that do not appear ill, move around normally, speak well, are capable to work. It is an unbelievable turn of events. No physician ever, who has not seen such a patient, would believe that anything like this is possible. The top professors of No.1 medical school in Abuja, Nigeria, became instant believers in BCRO FCT when they witnessed (with me) such change in patients in 2008. Such therapy was designed by my teacher, Prof.Dr. Franz Schmid, who chaired the two committees of German Gesundheits- amt, that supervised this treatment in West Germany in 1980’s.


9/ Autoimmune diseases

are all untreatable. When cortisone fails to to work, only BCRO FCT can rescue the patient from certain death.


10/ Cancer treatment

results could be substantially better if the Big Pharma would allow the modification of their standard therapeutic protocol by:

a/ replacement of the extensive aggressive surgery with resection of tumor with large margins of healthy tissue by removal of only the necrotic center of the tumor,

b/ lowering dose of radiation to 3,000 cgy only,

c/ lowering the dose of chemotherapy to 20 – 30% of their standard required doses,

d/ acknowledging the similarity of immune system function between pregnancy and cancer, and allowing the use of BCRO FCT to modify immune system function from that favoring the cancer to that bringing the immune system function to that found typically in pregnancy, since it is no secret that pregnancy prevents cancer,

e/ including in the cancer treatment is also the balancing of bio-energetic flows in the body by regular electromagnetic treatment of hypothalamus, the ‘master gland of the internal milieu of the body’, a contribution of the Chinese and Korean medicine to the cancer treatment.


11/ Hematologic diseases

that are incurable but can be successfully treated by BCRO FCT: sickle cell anemia, thalassemias, hemolytic anemias, porphyrias, hemochromatosis, genetic thrombo-embolic diseases, thrombocytopenic purpuras.


12/Diseases of central nervous system,

nearly 100% incurable even today – with an exception of Parkinson’s disease, temporarily treatable by L-Dopa – have, as a result of work of Prof.Dr. Saveliev and his team of neurophysiologists of Russian Academy of Sciences and neurosurgeon Prof.Dr. Lebedev and his team, with the help of our International Institute in Moscow in 1990 – 1997, become ‘bright stars of medicine’, confirmed later on by E.M.Molnar, M.D in Germany, Hong Kong, Indonesia, India, Slovakia, South Africa, and elsewhere in the world, also on himself(!), when he got very bad stroke on August 22, 2016, and by the phenomenal success of treatment of dementias, including stage 4 of Alzheimer’s disease, by BCRO FCT via intrathecal implantation (by lumbar puncture).

Along the way the treatment of great majority of incurable diseases of central nervous system has been found by us in Moscow, and elsewhere in the world by E.M. Molnar, M.D.: prolonged coma, untreatable Parkinson’s disease and syndrome, cerebro-vascular accidents, intracranial hematomas, paralyses due to spinal cord injuries, amyotrophic lateral sclerosis, encephalitis, ‘locked-in-syndrome’, all neurodegenerative diseases, i.e. multiple sclerosis, Friedreich’s ataxia, amaurotic idiocy, tuberous sclerosis, neural muscular atrophies, Duchenne and Becker muscular dystrophies, myasthenia gravis, Wilson’s disease, etc. Successful treatment of apallic syndrome in children less than 12 years old was was successfully accomplished by Prof.Dr. Franz Schmid, the replacement of Prof.Dr. Paul Niehans, the first king of cell therapy.

(Follow this fascinating story in my https://bio-cellular-research.com, where you can read more about everything that is summarized here. Warning: IT IS A VERY DIFFICULT READING FOR PHYSICIANS AS WELL. However, the best is to read my article presented to the medical conference in Orlando, Florida, U.S., in November 2015: “Treatment of incurable neurological diseases, including dementia, by BCRO fetal cell transplantation.”


13/ Genetic disorders of connective tissue

have been successfully treated by BCRO FCT: Marfan’s syndrome, osteogenesis imperfecta, achondroplasia, etc.


14/ Diseases of digestive system,

incurable, treatable only by BCRO FCT, with success, such as chronic pancreatitis, Crohn’s disease, ulcerative colitis, Hirschsprung’s disease, etc.


15/ Liver diseases,

incurable, treatable solely by BCRO FCT: liver cirrhosis, chronic hepatitis, hepato-renal syndrome, etc.


16/ Genetic hypercholesterolemias,

which represent 20% of patients with high cholesterol, for whom BCRO FCT has been the sole life prolonging treatment.


17/ Kidney diseases,

multiple, all genetic, incurable, treatable solely by BCRO FCT. - Beware, acute kidney failure cannot(!) be helped by fetal cell transplantation whatsoever and in chronic kidney failure it is already too late(!) for BCRO FTC.


18/ Cardiovascular diseases:

There is only one definitive treatment for untreatable diseases of the conductive system of the heart: BCRO FCT transplantation, replacing the whole “conductive system of the heart”. It was created some 7 years ago for treatment of my wife and used thus far in 7 patients beyond help, with 100% success rate.

Recommended treatment of myocardial infarction was developed in the medical schools in Paris, France and Dusseldorf and Hannover, Germany, and modified by E.M. Molnar M.D., (requires maintaining at all major cardiovascular centers in the world, that want use it, a laboratory for continuous preparation of xeno-geneic myocardial cell transplants) that are implanted in the damaged heart immediately upon arrival in all new myocardial infarction patients, which would decrease the myocardial cell loss due MI by 50% and thus turn untreatable heart attack patients into live human beings. Fetal cell transplantation can be done also the usual way when the clinical situation is not so urgent.

Also succesful treatment of peripheral arterial disease and migraine by BCRO FCT was described.


19/ Lung diseases:

Successful treatment of intractable bronchial asthma in children, cystic fibrosis, senile lungs, emphysema, pulmonary fibrosis, by BCRO FCT has been carried out.


20/ Treatment of 3rd degree non-treatable infected burns (due to antibiotics resistance)

– common problem of every burn center in the world.

In Moscow Burn Center we treated a consecutive 35 patients, who were hospitalized for many weeks with infected 3rd degree burns, because they could not receive skin grafts due to untreatable infection ot the burned skin. Without exception, their recalcitrant skin infection was subdued in 2 days with IIBM fetal cell transplantation, followed by uneventful full thickness skin graft, and a discharge from hospital in 10 days. It was reported at 10th World Congress of Burn Surgery in Paris, France, in 1995, and subsequently – due to low cost - at the All-India Congress of burn surgery in India.